⌘K

Home/Filings/4/0001127602-20-031788

4//SEC Filing

Babu Yarlagadda S 4

Accession 0001127602-20-031788

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:30 PM ET

Size

5.1 KB

Accession

0001127602-20-031788

Insider Transaction Report

Form 4

Period: 2020-12-15

BIOCRYST PHARMACEUTICALS INCBCRX

Babu Yarlagadda S

VP Drug Discovery

Transactions

Award
Emp. Stock Option (Right to Buy)
2020-12-15+280,000→ 280,000 total
Exercise: $8.31From: 2021-12-15Exp: 2030-12-15→ Common Stock (280,000 underlying)

Footnotes (1)

[F1]Annual Employee Option Grant becomes exercisable at the rate of 25% of each of the first, second, third and fourth anniversaries of the date of grant.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001452635

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 4:30 PM ET
Size: 5.1 KB

View on SEC.gov